Acute digital ischemia (Blue finger syndrome)
Specialty: Cardiovascular.
Why it occurs
- Cholesterol crystal embolism (atheroembolism) from proximal ulcerated plaques (aorta, iliofemoral arteries)
- In situ thrombosis due to antiphospholipid antibodies or severe hypercoagulability
- Idiopathic arterial spasm or due to exposure to extreme cold
- Embolism of cardiac origin (atrial fibrillation, infective endocarditis, myxoma)
- Secondary Raynaud's phenomenon with fixed microvascular occlusion
- Consumption of cocaine or amphetamines with induction of severe vasospasm
Initial workup
General analysis with complete blood count (search for eosinophilia), erythrocyte sedimentation rate, C-reactive protein, serum creatinine and urinary sediment to rule out concomitant renal involvement; Arterial Doppler ultrasound of the affected extremity and transesophageal echocardiogram to look for the source of embolism (complex aortic plaques, valvular vegetations or atrial thrombi); Computed tomography angiography (CT-Angio) of the aorta and peripheral vessels.
red flags
Sudden appearance of a purple, blue or black discoloration in one or more fingers or toes, with maintenance of palpable proximal arterial pulses (pedius, posterior tibial or radial), associated with exquisite acute pain of a burning nature, clear localized coldness, diffuse livedo reticularis in the lower extremities, or signs of multiple organ dysfunction (acute kidney failure, eosinophilia or eosinophiluria) after a recent cardiac catheterization or initiation of anticoagulant therapy. Indicates atheroembolism or disseminated microthrombosis with risk of irreversible focal tissue necrosis and loss of the phalanx.
Standard management
- Iloprost — prostacyclin analog indicated to induce vasodilation of microcirculation and suppress platelet aggregation; 0.5 to 2 ng/kg/min daily intravenous infusion over 6 hours for 5 to 10 days
- Acetylsalicylic acid — antiplatelet agent indicated to prevent platelet aggregation on endothelial microfissures; 100 mg per day orally
- Clopidogrel — 75 mg per day orally as alternative or adjuvant therapy
- Alprostadil — prostaglandin E1, indicated if iloprost is not available; 20 to 40 mcg intravenous as a slow infusion
- Atorvastatin (high-potency statin to promote the regression and stabilization of the ulcerated atheromatous plaque that is the source of cholesterol emboli; 80 mg per day orally).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 6
- Treatment options
- 5